ES476780A3 - Procedure for preparing a polypeptide capable of reducing the levels of calcium in the blood, and a salt of acid addition or complex thereof. (Machine-translation by Google Translate, not legally binding) - Google Patents

Procedure for preparing a polypeptide capable of reducing the levels of calcium in the blood, and a salt of acid addition or complex thereof. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES476780A3
ES476780A3 ES476780A ES476780A ES476780A3 ES 476780 A3 ES476780 A3 ES 476780A3 ES 476780 A ES476780 A ES 476780A ES 476780 A ES476780 A ES 476780A ES 476780 A3 ES476780 A3 ES 476780A3
Authority
ES
Spain
Prior art keywords
blood
reducing
levels
calcium
polypeptide capable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES476780A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Jozo KK
Original Assignee
Toyo Jozo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Jozo KK filed Critical Toyo Jozo KK
Priority to ES476780A priority Critical patent/ES476780A3/en
Publication of ES476780A3 publication Critical patent/ES476780A3/en
Expired legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Method of preparing a polypeptide capable of reducing the levels of calcium in the blood. Calcitonin is a well-known polypeptide capable of reducing calcium levels in the blood. It can be isolated from the mammalian thyroid gland or from the ultimobranchial gland of birds and fish. The amino acid sequence of calcitonin depends on the species from which it was obtained, having recently synthesized calcitonins endowed with the same chemical structure as those of natural origin. (Machine-translation by Google Translate, not legally binding)
ES476780A 1979-01-11 1979-01-11 Procedure for preparing a polypeptide capable of reducing the levels of calcium in the blood, and a salt of acid addition or complex thereof. (Machine-translation by Google Translate, not legally binding) Expired ES476780A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES476780A ES476780A3 (en) 1979-01-11 1979-01-11 Procedure for preparing a polypeptide capable of reducing the levels of calcium in the blood, and a salt of acid addition or complex thereof. (Machine-translation by Google Translate, not legally binding)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES476780A ES476780A3 (en) 1979-01-11 1979-01-11 Procedure for preparing a polypeptide capable of reducing the levels of calcium in the blood, and a salt of acid addition or complex thereof. (Machine-translation by Google Translate, not legally binding)

Publications (1)

Publication Number Publication Date
ES476780A3 true ES476780A3 (en) 1979-06-16

Family

ID=8477432

Family Applications (1)

Application Number Title Priority Date Filing Date
ES476780A Expired ES476780A3 (en) 1979-01-11 1979-01-11 Procedure for preparing a polypeptide capable of reducing the levels of calcium in the blood, and a salt of acid addition or complex thereof. (Machine-translation by Google Translate, not legally binding)

Country Status (1)

Country Link
ES (1) ES476780A3 (en)

Similar Documents

Publication Publication Date Title
Stoeckel et al. Purification of nerve growth factor antibodies by affinity chromatography
DE69839425D1 (en) NUCLEIC ACID BINDING PROTEINS
EP0355460A3 (en) Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis or chemical derivatization
DE69130289D1 (en) THERAPEUTIC USE OF ACTIN BINDING COMPOUNDS
KR890003799A (en) How to separate basic protein from mixture containing basic protein
KR910700264A (en) Somatotropin analog
ATE123949T1 (en) B-CHAIN ANALOGUES OF THE PLATELET-DERIVED GROWTH FACTOR AND METHOD FOR THE HOMOGENEOUS PRODUCTION THEREOF.
EP0147193A3 (en) Peptide production and use thereof
DK430486D0 (en) PROCEDURE FOR THE EXTRACTION OF PROTEIN
ES8507473A1 (en) Glycine - 8 calcitonin
DK390689A (en) PROCEDURE FOR PREPARING DES-B30 INSULINES AND DES-B30 INSULIN DERIVATIVES
Rieker et al. Phylogenetic distribution of peptides related to chromogranins A and B
IE42521L (en) Treating a sodium lauryl sulphate-whey protein complex.
ES476780A3 (en) Procedure for preparing a polypeptide capable of reducing the levels of calcium in the blood, and a salt of acid addition or complex thereof. (Machine-translation by Google Translate, not legally binding)
GR78453B (en)
Nagata et al. Distribution of the low molecular weight form of eukaryotic elongation factor 1 in various tissues
GB1042194A (en) Insulin preparations
FI881122A (en) Method for isolating basement membrane proteins from human and animal tissues
ES476781A3 (en) Procedure for the preparation of a new polypeptide and its salts and complexes of acid addition. (Machine-translation by Google Translate, not legally binding)
ATE3981T1 (en) PROCEDURE FOR OBTAINING ALPHA-2 SBGLYCOPROTEIN.
GB1532128A (en) Polypeptide obtained from a sea anemone
GB1456276A (en) Process of preparing an ointment
EP0191869A4 (en) Fish calcitonin derivative, process for its preparation, and gene system therefor.
JPS5430385A (en) Program hunting method of sequence controller
GB1413799A (en) Serological reagent